Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by activating brown adipose tissue in nontransgenic controls.
Chronic low-grade inflammation plays an important role in the pathogenesis of insulin resistance. In the current study, we tested the effects of salsalate, a non-steroidal anti-inflammatory drug, in an animal model of inflammation and metabolic syndrome using spontaneously hypertensive rats (SHR) th...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5460879?pdf=render |
id |
doaj-8f616313fe6841dd9e8fec56bd41364a |
---|---|
record_format |
Article |
spelling |
doaj-8f616313fe6841dd9e8fec56bd41364a2020-11-25T00:08:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01126e017906310.1371/journal.pone.0179063Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by activating brown adipose tissue in nontransgenic controls.Jaroslava TrnovskáJan ŠilhavýOndřej KudaVladimír LandaVáclav ZídekPetr MlejnekMiroslava ŠimákováHynek StrnadVojtěch ŠkopOlena OliyarnykLudmila KazdováMartin HaluzíkMichal PravenecChronic low-grade inflammation plays an important role in the pathogenesis of insulin resistance. In the current study, we tested the effects of salsalate, a non-steroidal anti-inflammatory drug, in an animal model of inflammation and metabolic syndrome using spontaneously hypertensive rats (SHR) that transgenically express human C-reactive protein (SHR-CRP rats). We treated 15-month-old male transgenic SHR-CRP rats and nontransgenic SHR with salsalate (200 mg/kg/day) mixed as part of a standard diet for 4 weeks. A corresponding untreated control group of male transgenic SHR-CRP and SHR rats were fed a standard diet without salsalate. In the SHR-CRP transgenic strain, salsalate treatment decreased circulating concentrations of the inflammatory markers TNF-α and MCP-1, reduced oxidative stress in the liver and kidney, increased sensitivity of skeletal muscles to insulin action and improved tolerance to glucose. In SHR controls with no CRP-induced inflammation, salsalate treatment reduced body weight, decreased concentrations of serum free fatty acids and total and HDL cholesterol and increased palmitate oxidation and incorporation in brown adipose tissue. Salsalate regulated inflammation by affecting the expression of genes from MAPK signalling and NOD-like receptor signalling pathways and lipid metabolism by affecting hepatic expression of genes that favour lipid oxidation from PPAR-α signalling pathways. These findings suggest that salsalate has metabolic effects beyond suppressing inflammation.http://europepmc.org/articles/PMC5460879?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jaroslava Trnovská Jan Šilhavý Ondřej Kuda Vladimír Landa Václav Zídek Petr Mlejnek Miroslava Šimáková Hynek Strnad Vojtěch Škop Olena Oliyarnyk Ludmila Kazdová Martin Haluzík Michal Pravenec |
spellingShingle |
Jaroslava Trnovská Jan Šilhavý Ondřej Kuda Vladimír Landa Václav Zídek Petr Mlejnek Miroslava Šimáková Hynek Strnad Vojtěch Škop Olena Oliyarnyk Ludmila Kazdová Martin Haluzík Michal Pravenec Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by activating brown adipose tissue in nontransgenic controls. PLoS ONE |
author_facet |
Jaroslava Trnovská Jan Šilhavý Ondřej Kuda Vladimír Landa Václav Zídek Petr Mlejnek Miroslava Šimáková Hynek Strnad Vojtěch Škop Olena Oliyarnyk Ludmila Kazdová Martin Haluzík Michal Pravenec |
author_sort |
Jaroslava Trnovská |
title |
Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by activating brown adipose tissue in nontransgenic controls. |
title_short |
Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by activating brown adipose tissue in nontransgenic controls. |
title_full |
Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by activating brown adipose tissue in nontransgenic controls. |
title_fullStr |
Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by activating brown adipose tissue in nontransgenic controls. |
title_full_unstemmed |
Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by activating brown adipose tissue in nontransgenic controls. |
title_sort |
salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human c-reactive protein and by activating brown adipose tissue in nontransgenic controls. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2017-01-01 |
description |
Chronic low-grade inflammation plays an important role in the pathogenesis of insulin resistance. In the current study, we tested the effects of salsalate, a non-steroidal anti-inflammatory drug, in an animal model of inflammation and metabolic syndrome using spontaneously hypertensive rats (SHR) that transgenically express human C-reactive protein (SHR-CRP rats). We treated 15-month-old male transgenic SHR-CRP rats and nontransgenic SHR with salsalate (200 mg/kg/day) mixed as part of a standard diet for 4 weeks. A corresponding untreated control group of male transgenic SHR-CRP and SHR rats were fed a standard diet without salsalate. In the SHR-CRP transgenic strain, salsalate treatment decreased circulating concentrations of the inflammatory markers TNF-α and MCP-1, reduced oxidative stress in the liver and kidney, increased sensitivity of skeletal muscles to insulin action and improved tolerance to glucose. In SHR controls with no CRP-induced inflammation, salsalate treatment reduced body weight, decreased concentrations of serum free fatty acids and total and HDL cholesterol and increased palmitate oxidation and incorporation in brown adipose tissue. Salsalate regulated inflammation by affecting the expression of genes from MAPK signalling and NOD-like receptor signalling pathways and lipid metabolism by affecting hepatic expression of genes that favour lipid oxidation from PPAR-α signalling pathways. These findings suggest that salsalate has metabolic effects beyond suppressing inflammation. |
url |
http://europepmc.org/articles/PMC5460879?pdf=render |
work_keys_str_mv |
AT jaroslavatrnovska salsalateamelioratesmetabolicdisturbancesbyreducinginflammationinspontaneouslyhypertensiveratsexpressinghumancreactiveproteinandbyactivatingbrownadiposetissueinnontransgeniccontrols AT jansilhavy salsalateamelioratesmetabolicdisturbancesbyreducinginflammationinspontaneouslyhypertensiveratsexpressinghumancreactiveproteinandbyactivatingbrownadiposetissueinnontransgeniccontrols AT ondrejkuda salsalateamelioratesmetabolicdisturbancesbyreducinginflammationinspontaneouslyhypertensiveratsexpressinghumancreactiveproteinandbyactivatingbrownadiposetissueinnontransgeniccontrols AT vladimirlanda salsalateamelioratesmetabolicdisturbancesbyreducinginflammationinspontaneouslyhypertensiveratsexpressinghumancreactiveproteinandbyactivatingbrownadiposetissueinnontransgeniccontrols AT vaclavzidek salsalateamelioratesmetabolicdisturbancesbyreducinginflammationinspontaneouslyhypertensiveratsexpressinghumancreactiveproteinandbyactivatingbrownadiposetissueinnontransgeniccontrols AT petrmlejnek salsalateamelioratesmetabolicdisturbancesbyreducinginflammationinspontaneouslyhypertensiveratsexpressinghumancreactiveproteinandbyactivatingbrownadiposetissueinnontransgeniccontrols AT miroslavasimakova salsalateamelioratesmetabolicdisturbancesbyreducinginflammationinspontaneouslyhypertensiveratsexpressinghumancreactiveproteinandbyactivatingbrownadiposetissueinnontransgeniccontrols AT hynekstrnad salsalateamelioratesmetabolicdisturbancesbyreducinginflammationinspontaneouslyhypertensiveratsexpressinghumancreactiveproteinandbyactivatingbrownadiposetissueinnontransgeniccontrols AT vojtechskop salsalateamelioratesmetabolicdisturbancesbyreducinginflammationinspontaneouslyhypertensiveratsexpressinghumancreactiveproteinandbyactivatingbrownadiposetissueinnontransgeniccontrols AT olenaoliyarnyk salsalateamelioratesmetabolicdisturbancesbyreducinginflammationinspontaneouslyhypertensiveratsexpressinghumancreactiveproteinandbyactivatingbrownadiposetissueinnontransgeniccontrols AT ludmilakazdova salsalateamelioratesmetabolicdisturbancesbyreducinginflammationinspontaneouslyhypertensiveratsexpressinghumancreactiveproteinandbyactivatingbrownadiposetissueinnontransgeniccontrols AT martinhaluzik salsalateamelioratesmetabolicdisturbancesbyreducinginflammationinspontaneouslyhypertensiveratsexpressinghumancreactiveproteinandbyactivatingbrownadiposetissueinnontransgeniccontrols AT michalpravenec salsalateamelioratesmetabolicdisturbancesbyreducinginflammationinspontaneouslyhypertensiveratsexpressinghumancreactiveproteinandbyactivatingbrownadiposetissueinnontransgeniccontrols |
_version_ |
1725414987200987136 |